"This is an exciting moment and I'm delighted that Dr. Jordan will be contributing to significant research activities in breast cancer here," Dr. Ron DePinho, president of M.D. Anderson," said in a statement. "His international reputation as a trailblazer in translation research and his many achievements and honors are well deserved."